既往 B 细胞清除后阿替利珠单抗与贝伐珠单抗治疗肝细胞癌获完全缓解 Complete Remission of Hepatocellular Carcinoma With Atezolizumab and Bevacizumab Following Prior B-cell Depletion. PubMed 2026/01/01 发表J ImmunotherQ3 · IF 2.9(JCR 2025) 靶点:CD20技术:NK 细胞弥漫大B细胞淋巴瘤肝细胞癌淋巴瘤地区:中国
KIR2DS2 表达标识具有增强抗癌活性的 NK 细胞 KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity. PubMed 2022/06/29 发表J ImmunolQ2 · IF 4(JCR 2025) 靶点:CD20技术:NK 细胞慢性淋巴细胞白血病肝癌淋巴瘤地区:欧洲